<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d467">
    <sentence id="DDI-DrugBank.d467.s0" text="No formal studies to evaluate drug interactions with bexarotene have been conducted.">
        <entity charOffset="53-62" id="DDI-DrugBank.d467.s0.e0" text="bexarotene" type="drug"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; formal studies to evaluate drug interactions with bexarotene have been conducted. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d467.s1" text="Bexarotene oxidative metabolites appear to be formed by cytochrome P450 3A4.">
        <entity charOffset="0-9" id="DDI-DrugBank.d467.s1.e0" text="Bexarotene" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d467.s2" text="On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.">
        <entity charOffset="34-43" id="DDI-DrugBank.d467.s2.e0" text="bexarotene" type="drug"/>
        <entity charOffset="69-80" id="DDI-DrugBank.d467.s2.e1" text="ketoconazole" type="drug"/>
        <entity charOffset="83-94" id="DDI-DrugBank.d467.s2.e2" text="itraconazole" type="drug"/>
        <entity charOffset="97-108" id="DDI-DrugBank.d467.s2.e3" text="erythromycin" type="drug"/>
        <entity charOffset="111-121" id="DDI-DrugBank.d467.s2.e4" text="gemfibrozil" type="drug"/>
        <entity charOffset="237-246" id="DDI-DrugBank.d467.s2.e5" text="bexarotene" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e0" e2="DDI-DrugBank.d467.s2.e1" id="DDI-DrugBank.d467.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e0" e2="DDI-DrugBank.d467.s2.e2" id="DDI-DrugBank.d467.s2.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e0" e2="DDI-DrugBank.d467.s2.e3" id="DDI-DrugBank.d467.s2.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e0" e2="DDI-DrugBank.d467.s2.e4" id="DDI-DrugBank.d467.s2.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e0" e2="DDI-DrugBank.d467.s2.e5" id="DDI-DrugBank.d467.s2.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e1" e2="DDI-DrugBank.d467.s2.e2" id="DDI-DrugBank.d467.s2.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e1" e2="DDI-DrugBank.d467.s2.e3" id="DDI-DrugBank.d467.s2.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e1" e2="DDI-DrugBank.d467.s2.e4" id="DDI-DrugBank.d467.s2.p7"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s2.e1" e2="DDI-DrugBank.d467.s2.e5" id="DDI-DrugBank.d467.s2.p8" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e2" e2="DDI-DrugBank.d467.s2.e3" id="DDI-DrugBank.d467.s2.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e2" e2="DDI-DrugBank.d467.s2.e4" id="DDI-DrugBank.d467.s2.p10"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s2.e2" e2="DDI-DrugBank.d467.s2.e5" id="DDI-DrugBank.d467.s2.p11" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s2.e3" e2="DDI-DrugBank.d467.s2.e4" id="DDI-DrugBank.d467.s2.p12"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s2.e3" e2="DDI-DrugBank.d467.s2.e5" id="DDI-DrugBank.d467.s2.p13" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s2.e4" e2="DDI-DrugBank.d467.s2.e5" id="DDI-DrugBank.d467.s2.p14" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d467.s3" text="Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.">
        <entity charOffset="13-20" id="DDI-DrugBank.d467.s3.e0" text="rifampin" type="drug"/>
        <entity charOffset="23-31" id="DDI-DrugBank.d467.s3.e1" text="phenytoin" type="drug"/>
        <entity charOffset="34-46" id="DDI-DrugBank.d467.s3.e2" text="phenobarbital" type="drug"/>
        <entity charOffset="123-132" id="DDI-DrugBank.d467.s3.e3" text="bexarotene" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s3.e0" e2="DDI-DrugBank.d467.s3.e1" id="DDI-DrugBank.d467.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s3.e0" e2="DDI-DrugBank.d467.s3.e2" id="DDI-DrugBank.d467.s3.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s3.e0" e2="DDI-DrugBank.d467.s3.e3" id="DDI-DrugBank.d467.s3.p2" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s3.e1" e2="DDI-DrugBank.d467.s3.e2" id="DDI-DrugBank.d467.s3.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s3.e1" e2="DDI-DrugBank.d467.s3.e3" id="DDI-DrugBank.d467.s3.p4" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s3.e2" e2="DDI-DrugBank.d467.s3.e3" id="DDI-DrugBank.d467.s3.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d467.s4" text="Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.">
        <entity charOffset="30-38" id="DDI-DrugBank.d467.s4.e0" text="Targretin" type="brand"/>
        <entity charOffset="53-63" id="DDI-DrugBank.d467.s4.e1" text="gemfibrozil" type="drug"/>
        <entity charOffset="127-136" id="DDI-DrugBank.d467.s4.e2" text="bexarotene" type="drug"/>
        <entity charOffset="212-222" id="DDI-DrugBank.d467.s4.e3" text="gemfibrozil" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s4.e0" e2="DDI-DrugBank.d467.s4.e1" id="DDI-DrugBank.d467.s4.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s4.e0" e2="DDI-DrugBank.d467.s4.e2" id="DDI-DrugBank.d467.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s4.e0" e2="DDI-DrugBank.d467.s4.e3" id="DDI-DrugBank.d467.s4.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s4.e1" e2="DDI-DrugBank.d467.s4.e2" id="DDI-DrugBank.d467.s4.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s4.e1" e2="DDI-DrugBank.d467.s4.e3" id="DDI-DrugBank.d467.s4.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s4.e2" e2="DDI-DrugBank.d467.s4.e3" id="DDI-DrugBank.d467.s4.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d467.s5" text="Under similar conditions, bexarotene concentrations were not affected by concomitant atorvastatin administration.">
        <entity charOffset="26-35" id="DDI-DrugBank.d467.s5.e0" text="bexarotene" type="drug"/>
        <entity charOffset="85-96" id="DDI-DrugBank.d467.s5.e1" text="atorvastatin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d467.s5.e0" e2="DDI-DrugBank.d467.s5.e1" id="DDI-DrugBank.d467.s5.p0"/>
    <negationtags>Under similar conditions, bexarotene concentrations were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affected by concomitant atorvastatin administration. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d467.s6" text="Concomitant administration of gemfibrozil with Targretin capsules is not recommended.">
        <entity charOffset="30-40" id="DDI-DrugBank.d467.s6.e0" text="gemfibrozil" type="drug"/>
        <entity charOffset="47-55" id="DDI-DrugBank.d467.s6.e1" text="Targretin" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d467.s6.e0" e2="DDI-DrugBank.d467.s6.e1" id="DDI-DrugBank.d467.s6.p0" type="advise"/>
    <negationtags>Concomitant administration of gemfibrozil with Targretin capsules is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; recommended. &lt;/scope&gt;</negationtags></sentence>
</document>